Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Douglas Corley and Lawrence Kushi.
Douglas Corley
Connection Strength
0.858
Lawrence Kushi
  1. Risk of severe clinical outcomes among persons with SARS-CoV-2 infection with differing levels of vaccination during widespread Omicron (B.1.1.529) and Delta (B.1.617.2) variant circulation in Northern California: A retrospective cohort study. Lancet Reg Health Am. 2022 Aug; 12:100297.
    View in: PubMed
    Score: 0.210
  2. Primary care visit use after positive fecal immunochemical test for colorectal cancer screening. Cancer. 2017 Oct 01; 123(19):3744-3753.
    View in: PubMed
    Score: 0.149
  3. Unraveling the genetic landscape of susceptibility to multiple primary cancers. medRxiv. 2024 Oct 30.
    View in: PubMed
    Score: 0.062
  4. Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system. PLoS One. 2024; 19(6):e0303303.
    View in: PubMed
    Score: 0.060
  5. Relative contribution of COVID-19 vaccination and SARS-CoV-2 infection to population-level seroprevalence of SARS-CoV-2 spike antibodies in a large integrated health system. medRxiv. 2024 Feb 02.
    View in: PubMed
    Score: 0.059
  6. Assessment of genetic susceptibility to multiple primary cancers through whole-exome sequencing in two large multi-ancestry studies. BMC Med. 2022 10 06; 20(1):332.
    View in: PubMed
    Score: 0.054
  7. Mission, Organization, and Future Direction of the Serological Sciences Network for COVID-19 (SeroNet) Epidemiologic Cohort Studies. Open Forum Infect Dis. 2022 Jun; 9(6):ofac171.
    View in: PubMed
    Score: 0.052
  8. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.048
  9. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.046
  10. Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network. JCO Clin Cancer Inform. 2019 09; 3:1-10.
    View in: PubMed
    Score: 0.043
  11. Collaborating on Data, Science, and Infrastructure: The 20-Year Journey of the Cancer Research Network. EGEMS (Wash DC). 2019 Mar 29; 7(1):7.
    View in: PubMed
    Score: 0.042
  12. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.032

© 2024 Kaiser Permanente